Target Name: ZMIZ2
NCBI ID: G83637
Review Report on ZMIZ2 Target / Biomarker Content of Review Report on ZMIZ2 Target / Biomarker
ZMIZ2
Other Name(s): ZMIZ2_HUMAN | ZIMP7 | zinc finger MIZ-type containing 2 | hZIMP7 | TRAFIP20 | ZMIZ2 variant 1 | Zinc finger MIZ domain-containing protein 2 (isoform 1) | Zinc finger MIZ domain-containing protein 2 | PIAS-like protein Zimp7 | KIAA1886 | NET27 | Zinc finger MIZ-type containing 2, transcript variant 1

ZMIR: A Potential Drug Target and Biomarker for Diseases

ZMIZ2 (ZMIZ2_HUMAN), a gene product of the zebrafish species, has been identified as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. ZMIZ2 is a gene that encodes a protein known as zebrafish mitochondrial intracellular resistance (ZMIR), which plays a crucial role in the regulation of mitochondrial function and metabolism.

The ZMIR protein is a key component of the mitochondrial inner membrane, which is the boundary between the mitochondria and the cytoplasm. The ZMIR protein helps to maintain the stability of the mitochondrial inner membrane and is involved in various cellular processes, including energy metabolism, cell signaling, and stress resistance.

Studies have shown that alterations in ZMIR levels or function have been implicated in the development and progression of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. For example, ZMIR has been shown to be overexpressed in various cancer types, including breast, ovarian, and colorectal cancers. Additionally, ZMIR has been linked to neurodegenerative disorders, including Alzheimer's disease, Parkinson's disease, and Huntington's disease.

In addition to its potential as a drug target, ZMIR has also been identified as a potential biomarker for various diseases. The ZMIR protein is expressed in various tissues and cells, including cancer cells, neurons, and glial cells in the central nervous system. Therefore, it may be a useful biomarker for the diagnosis and monitoring of various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases.

One of the challenges in studying ZMIR is its expression and function in different organisms and tissues. However, researchers have been able to study ZMIR in various models, including zebrafish, mouse, and human samples. For example, studies have shown that ZMIR is expressed and functions similarly in zebrafish and mouse models of cancer, neurodegenerative disorders, and autoimmune diseases.

In addition to its potential as a drug target and biomarker, ZMIR also has potential as a research tool for studying cellular and molecular mechanisms underlying disease. For example, researchers have used ZMIR to study the effects of drugs on mitochondrial function and metabolism, as well as the role of the ZMIR protein in modulating cellular signaling pathways.

Overall, ZMIR is a promising drug target and biomarker for various diseases, including cancer, neurodegenerative disorders, and autoimmune diseases. Further research is needed to fully understand its role and potential as a therapeutic agent.

Protein Name: Zinc Finger MIZ-type Containing 2

Functions: Increases ligand-dependent transcriptional activity of AR and other nuclear hormone receptors

The "ZMIZ2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZMIZ2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ZMPSTE24 | ZMYM1 | ZMYM2 | ZMYM3 | ZMYM4 | ZMYM4-AS1 | ZMYM5 | ZMYM6 | ZMYND10 | ZMYND11 | ZMYND12 | ZMYND15 | ZMYND19 | ZMYND8 | ZNF10 | ZNF100 | ZNF101 | ZNF106 | ZNF107 | ZNF112 | ZNF114 | ZNF117 | ZNF12 | ZNF121 | ZNF124 | ZNF131 | ZNF132 | ZNF133 | ZNF134 | ZNF135 | ZNF136 | ZNF137P | ZNF138 | ZNF14 | ZNF140 | ZNF141 | ZNF142 | ZNF143 | ZNF146 | ZNF148 | ZNF154 | ZNF155 | ZNF157 | ZNF16 | ZNF160 | ZNF165 | ZNF169 | ZNF17 | ZNF174 | ZNF175 | ZNF177 | ZNF18 | ZNF180 | ZNF181 | ZNF182 | ZNF184 | ZNF185 | ZNF189 | ZNF19 | ZNF195 | ZNF197 | ZNF2 | ZNF20 | ZNF200 | ZNF202 | ZNF204P | ZNF205 | ZNF205-AS1 | ZNF207 | ZNF208 | ZNF209P | ZNF211 | ZNF212 | ZNF213 | ZNF213-AS1 | ZNF214 | ZNF215 | ZNF217 | ZNF219 | ZNF22 | ZNF22-AS1 | ZNF221 | ZNF222 | ZNF223 | ZNF224 | ZNF225 | ZNF225-AS1 | ZNF226 | ZNF227 | ZNF229 | ZNF23 | ZNF230 | ZNF232 | ZNF232-AS1 | ZNF233 | ZNF234 | ZNF235 | ZNF236 | ZNF236-DT | ZNF239